We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Treatment of Painful Flat Feet May Soon Be Redundant

By HospiMedica International staff writers
Posted on 01 Feb 2012
New research suggests that adult-acquired flat foot resulting from the gradual stretching of the tibialis posterior tendon (PTT) due to changes in matrix protein biochemistry could eventually be treated in a nonsurgical manner.

Researchers at the University of East Anglia (UEA; Norwich, United Kingdom), the University of Bristol (United Kingdom), and other institutions obtained normal PTTs from patients with no history of tendon problems. More...
Samples of dysfunctional PTT and replacement flexor digitorum longus tendon (FDLT) tissue were then obtained from patients undergoing surgical reconstruction. The samples were then analyzed and compared for total collagen and glycosaminoglycan (GAG), pentosidine, collagen cross-links, and the expression of matrix and metalloproteinase mRNA.

The results showed that dysfunctional PTT contained higher levels of GAG and lower levels of pentosidine than normal PTT or FDLT. In contrast, collagen in FDLT contained fewer ketoimine and more aldimine cross-links than either normal or dysfunctional PTT. mRNA encoding types I and III collagens, aggrecan, biglycan, MMP-2, -13 and -23, and a disintegrin and metalloproteinase (ADAM)-12L each showed increased levels in dysfunctional PTT compared with either normal PTT or FDLT. In principal, the findings suggest that over time the structure and composition of the tendons changes due to increased activity of proteolytic enzymes. These enzymes then break down the constituents of the PTT and weaken it, causing the foot arch to fall. The study was published on January 12, 2012, in Annals of the Rheumatic Diseases.

“Our study may have important therapeutic implications since the altered enzyme activity could be a target for new drug therapies in the future,” said lead author Graham Riley, PhD, of the UEA School of Biological Sciences. “We have shown that similar changes also take place in other painful tendon conditions such as Achilles tendonitis, so this advance may ultimately result in an effective alternative to surgery for many patients.”

Adult-acquired flat foot is most common in women over 40, and often goes undiagnosed. The condition results from the gradual “stretching out” over time of the PTT, the main stabilizer of the foot arch. The causes of this stretching are not fully understood, though some believe wearing high heels and standing or walking for long periods may play a role. Known risk factors for the condition include obesity, hypertension, and diabetes. Treatment usually involves surgical transfer of the FDLT.

Related Links:

University of East Anglia
University of Bristol



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.